Pharmabiz2d
FPME demands policy reforms to address critical issues hampering export ecosystem
The Federation of Pharmaceutical and Allied Products Merchant Exporters (FPME) has urged the authorities to address critical issues hampering India's pharmaceutical export ecosystem, highlighting the ...
Pharmabiz2d
Lupin’s ivacaftor oral granules receives US FDA tentative approval
Global pharma major Lupin Limited (Lupin) announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for ...
Pharmabiz2d
WHO prequalifies SD Biosensor’s STANDARD G6PD System to support safer administration of P. vivax malaria treatments
The World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended treatments to ...
Pharmabiz2d
NCH amends BHMS regulations to add goals, restructure curriculum and assessment process
The National Commission for Homoeopathy (NCH), the statutory body under the Ministry of Ayush to regulate the Homoeopathy education in the country, has amended the regulations related to Bachelor of ...
Pharmabiz2d
Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor
Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company leading the development of innovative, oral therapeutics for RAS-driven cancers, announced progress across its pipeline ...
Pharmabiz3d
Lupin receives US FDA tentative approval for loteprednol etabonate ophthalmic gel
Global pharma major Lupin Limited (Lupin) announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for ...
Pharmabiz2d
Bayer’s subsidiary, Vividion acquires Tavros Therapeutics to expand functional genomics capabilities and boost drug discovery platform
Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets and develop small molecule ...
Pharmabiz2d
Dr Sunita Tandulwadkar takes over as 63rd FOGSI president, unveils bold vision for transforming women’s healthcare in India
Dr Sunita Tandulwadkar, an internationally acclaimed infertility specialist, endoscopic surgeon, and gynaecologist, was formally installed as the 63rd president of the Federation of Obstetric and ...
Pharmabiz2d
AIPPSPA urges Kerala DCA to carry out separate inspections at discount pharmacies to ensure quality of drugs
Expressing concerns over the quality of medicines sold through discount pharmacies in Kerala, the state president of the All India Public and Private Sector Pharmacists Association (AIPPSPA), ...
Pharmabiz2d
Neuberg Diagnostics secures an investment of Rs. 940 crore from Kotak Alt
Neuberg Diagnostics, founded in 2017 and headquartered in Chennai, has rapidly emerged as the fastest-growing, largest integrated diagnostics player in the country and one of the top 4 largest ...
Pharmabiz2d
Novo Nordisk and Valo Health expand collaboration to discover and develop novel treatments for cardiometabolic diseases
Novo Nordisk A/S, a leading global healthcare company, and Valo Health, Inc. announced they have entered into an expanded agreement to discover and develop novel treatments for obesity, type 2 ...